These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 35753323)

  • 1. Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis.
    Ostuzzi G; Vita G; Bertolini F; Tedeschi F; De Luca B; Gastaldon C; Nosé M; Papola D; Purgato M; Del Giovane C; Correll CU; Barbui C
    Lancet Psychiatry; 2022 Aug; 9(8):614-624. PubMed ID: 35753323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.
    Rodolico A; Siafis S; Bighelli I; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014384. PubMed ID: 36420692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials.
    Højlund M; Kemp AF; Haddad PM; Neill JC; Correll CU
    Lancet Psychiatry; 2021 Jun; 8(6):471-486. PubMed ID: 34023019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.
    Kishimoto T; Hagi K; Kurokawa S; Kane JM; Correll CU
    Lancet Psychiatry; 2021 May; 8(5):387-404. PubMed ID: 33862018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysis.
    Farhat LC; Behling E; Landeros-Weisenberger A; Levine JLS; Macul Ferreira de Barros P; Wang Z; Bloch MH
    Lancet Child Adolesc Health; 2023 Feb; 7(2):112-126. PubMed ID: 36528030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of long-acting injectable
    Vita G; Tavella A; Ostuzzi G; Tedeschi F; De Prisco M; Segarra R; Solmi M; Barbui C; Correll CU
    Ther Adv Psychopharmacol; 2024; 14():20451253241257062. PubMed ID: 38831918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis.
    Schneider-Thoma J; Chalkou K; Dörries C; Bighelli I; Ceraso A; Huhn M; Siafis S; Davis JM; Cipriani A; Furukawa TA; Salanti G; Leucht S
    Lancet; 2022 Feb; 399(10327):824-836. PubMed ID: 35219395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole for schizophrenia.
    El-Sayeh HG; Morganti C
    Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD004578. PubMed ID: 16625607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole versus typicals for schizophrenia.
    Bhattacharjee J; El-Sayeh HG
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006617. PubMed ID: 18254107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepines for schizophrenia.
    Volz A; Khorsand V; Gillies D; Leucht S
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006391. PubMed ID: 17253592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance treatment with antipsychotic drugs for schizophrenia.
    Leucht S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM
    Cochrane Database Syst Rev; 2012 May; (5):CD008016. PubMed ID: 22592725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia.
    Bergman H; Walker DM; Nikolakopoulou A; Soares-Weiser K; Adams CE
    Health Technol Assess; 2017 Aug; 21(43):1-218. PubMed ID: 28812541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium for schizophrenia.
    Leucht S; Helfer B; Dold M; Kissling W; McGrath JJ
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003834. PubMed ID: 26509923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone versus typical antipsychotic medication for schizophrenia.
    Hunter RH; Joy CB; Kennedy E; Gilbody SM; Song F
    Cochrane Database Syst Rev; 2003; (2):CD000440. PubMed ID: 12804396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data.
    Efthimiou O; Taipale H; Radua J; Schneider-Thoma J; Pinzón-Espinosa J; Ortuño M; Vinkers CH; Mittendorfer-Rutz E; Cardoner N; Tanskanen A; Fusar-Poli P; Cipriani A; Vieta E; Leucht S; Tiihonen J; Luykx JJ
    Lancet Psychiatry; 2024 Feb; 11(2):102-111. PubMed ID: 38215784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.
    Huhn M; Nikolakopoulou A; Schneider-Thoma J; Krause M; Samara M; Peter N; Arndt T; Bäckers L; Rothe P; Cipriani A; Davis J; Salanti G; Leucht S
    Lancet; 2019 Sep; 394(10202):939-951. PubMed ID: 31303314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance Treatment With Antipsychotic Drugs in Schizophrenia: A Cochrane Systematic Review and Meta-analysis.
    Ceraso A; Lin JJ; Schneider-Thoma J; Siafis S; Heres S; Kissling W; Davis JM; Leucht S
    Schizophr Bull; 2022 Jun; 48(4):738-740. PubMed ID: 35556140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.